Moffitt logo

Clinical Trials Search

Clinical Trial 22157

Cancer Type: Breast
Study Type: Other

Phase: N/A
Principal Investigator: Lee, Kimberley

Call 813-745-6100
or 1-800-679-0775 Learn More

Study Title

A Mixed-Methods Study to Inform the Use of Patient Education and Digital Technology to Increase the Racial/Ethnic Diversity of Clinical Trial Participants



Specific Aims Aim 1: To examine patient perspectives on the use of patient navigation and digital technologies in clinical trial enrollment. Aim 1a. Surveys developed based on formative evaluation of the exiting literature will be administered to patient participants to validate external findings in this population as well as to develop a sense of preferences for intervention which will then guide development/refinement of interview guide. Aim 1b. Semi-structured interviews will be conducted to compliment surveys. By asking open-ended questions through semi-structured interviews, we allow participants to identify topics they understand as important, which may differ from survey questions. This inductive inquiry compliments survey findings by adding attention to context, complexities, and subjective meanings that are not easily quantified. Aim 2: To identify the systems- and clinician-level facilitators and barriers to intervention adoption.




Inclusion Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Able to speak and read English.
  • Diagnosed with breast cancer within the past 5 years.
  • Have no documented or observable severe or untreated neurological, psychiatric, or physical limitations that would preclude participation in this project.
  • Able to provide informed consent
  • Self-identify as Black or Hispanic.

  • Exclusion Criteria

    Exclusion Criteria:

  • Participants who do not meet the above inclusion criteria.

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.